NO992384L - Multivalente salter av pyridostigmin og relaterte forbindelser - Google Patents
Multivalente salter av pyridostigmin og relaterte forbindelserInfo
- Publication number
- NO992384L NO992384L NO992384A NO992384A NO992384L NO 992384 L NO992384 L NO 992384L NO 992384 A NO992384 A NO 992384A NO 992384 A NO992384 A NO 992384A NO 992384 L NO992384 L NO 992384L
- Authority
- NO
- Norway
- Prior art keywords
- anions
- modifications
- ring
- pyridostigmine
- related compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
- C07C271/42—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3118696P | 1996-11-19 | 1996-11-19 | |
| PCT/US1997/020509 WO1998022458A1 (en) | 1996-11-19 | 1997-11-10 | Multivalent salts of pyridostigmine and related compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO992384D0 NO992384D0 (no) | 1999-05-18 |
| NO992384L true NO992384L (no) | 1999-07-16 |
Family
ID=21858083
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO992384A NO992384L (no) | 1996-11-19 | 1999-05-18 | Multivalente salter av pyridostigmin og relaterte forbindelser |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6211201B1 (cs) |
| EP (1) | EP0941224A4 (cs) |
| JP (1) | JP2001505561A (cs) |
| KR (1) | KR20000069028A (cs) |
| CN (1) | CN1237969A (cs) |
| AU (1) | AU717740B2 (cs) |
| BR (1) | BR9713112A (cs) |
| CA (1) | CA2271786A1 (cs) |
| CZ (1) | CZ172799A3 (cs) |
| HU (1) | HUP9904040A3 (cs) |
| IL (1) | IL129619A0 (cs) |
| NO (1) | NO992384L (cs) |
| NZ (1) | NZ335419A (cs) |
| PL (1) | PL333414A1 (cs) |
| SI (1) | SI20018A (cs) |
| SK (1) | SK64399A3 (cs) |
| WO (1) | WO1998022458A1 (cs) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002092003A2 (en) * | 2001-05-11 | 2002-11-21 | Bacaner Marvin B | Novel therapeutical quaternary ammonium compositions |
| KR20050088992A (ko) | 2002-10-07 | 2005-09-07 | 더 리전트 오브 더 유니버시티 오브 캘리포니아 | 아난드아미드 가수분해 차단을 통한 불안감의 조절 |
| US20050182252A1 (en) | 2004-02-13 | 2005-08-18 | Reddy K. R. | Novel 2'-C-methyl nucleoside derivatives |
| AU2015217221A1 (en) | 2014-02-13 | 2016-08-11 | Ligand Pharmaceuticals, Inc. | Prodrug compounds and their uses |
| EP3164136A4 (en) | 2014-07-02 | 2018-04-04 | Ligand Pharmaceuticals, Inc. | Prodrug compounds and uses therof |
| CN107854428A (zh) * | 2016-12-20 | 2018-03-30 | 成都医学院 | 一种溴吡斯的明糖浆剂及其制备方法 |
| AU2019207625A1 (en) | 2018-01-09 | 2020-07-30 | Ligand Pharmaceuticals, Inc. | Acetal compounds and therapeutic uses thereof |
| CN113277961B (zh) * | 2021-04-09 | 2023-05-09 | 深圳市新浩瑞医药科技有限公司 | 一种溴新斯的明的合成方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4692530A (en) * | 1967-03-07 | 1987-09-08 | The United States Of America As Represented By The Secretary Of The Army | Chemical agents |
| US4686293A (en) * | 1967-05-29 | 1987-08-11 | The United States Of America As Represented By The Secretary Of The Army | Chemical agents |
| US4672120A (en) * | 1967-07-03 | 1987-06-09 | The United States Of America As Represented By The Secretary Of The Army | Chemical agents |
| US4246416A (en) * | 1967-12-01 | 1981-01-20 | The United States Of America As Represented By The Secretary Of The Army | Chemical agents |
| US4677222A (en) * | 1968-01-22 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Army | Ketobenzylcarbamates |
| US5534623A (en) * | 1993-01-21 | 1996-07-09 | Du Pont (Uk) Limited | Process for preparing a polyunsaturated diazonium compounds |
-
1997
- 1997-11-10 NZ NZ335419A patent/NZ335419A/xx not_active IP Right Cessation
- 1997-11-10 HU HU9904040A patent/HUP9904040A3/hu unknown
- 1997-11-10 EP EP97954835A patent/EP0941224A4/en not_active Withdrawn
- 1997-11-10 PL PL97333414A patent/PL333414A1/xx unknown
- 1997-11-10 KR KR1019997004410A patent/KR20000069028A/ko not_active Application Discontinuation
- 1997-11-10 US US09/308,723 patent/US6211201B1/en not_active Expired - Lifetime
- 1997-11-10 WO PCT/US1997/020509 patent/WO1998022458A1/en not_active Application Discontinuation
- 1997-11-10 BR BR9713112-1A patent/BR9713112A/pt not_active IP Right Cessation
- 1997-11-10 AU AU62367/98A patent/AU717740B2/en not_active Ceased
- 1997-11-10 SI SI9720075A patent/SI20018A/sl not_active IP Right Cessation
- 1997-11-10 CA CA002271786A patent/CA2271786A1/en not_active Abandoned
- 1997-11-10 CN CN97199841A patent/CN1237969A/zh active Pending
- 1997-11-10 SK SK643-99A patent/SK64399A3/sk unknown
- 1997-11-10 IL IL12961997A patent/IL129619A0/xx unknown
- 1997-11-10 JP JP52371598A patent/JP2001505561A/ja active Pending
- 1997-11-10 CZ CZ991727A patent/CZ172799A3/cs unknown
-
1999
- 1999-05-18 NO NO992384A patent/NO992384L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| SK64399A3 (en) | 2000-05-16 |
| CZ172799A3 (cs) | 1999-10-13 |
| PL333414A1 (en) | 1999-12-06 |
| BR9713112A (pt) | 2000-04-11 |
| JP2001505561A (ja) | 2001-04-24 |
| AU717740B2 (en) | 2000-03-30 |
| WO1998022458A1 (en) | 1998-05-28 |
| NZ335419A (en) | 2000-05-26 |
| CA2271786A1 (en) | 1998-05-28 |
| IL129619A0 (en) | 2000-02-29 |
| NO992384D0 (no) | 1999-05-18 |
| SI20018A (sl) | 2000-02-29 |
| EP0941224A4 (en) | 2000-01-12 |
| CN1237969A (zh) | 1999-12-08 |
| US6211201B1 (en) | 2001-04-03 |
| AU6236798A (en) | 1998-06-10 |
| HUP9904040A3 (en) | 2000-09-28 |
| KR20000069028A (ko) | 2000-11-25 |
| EP0941224A1 (en) | 1999-09-15 |
| HUP9904040A2 (hu) | 2000-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI972781A0 (fi) | Menetelmät ja koostumukset allergisen nuhan ja muiden sairauksien hoitamiseksi käyttäen dekarboetokyloratadieeniä | |
| NO992384L (no) | Multivalente salter av pyridostigmin og relaterte forbindelser | |
| BR9714677A (pt) | "enantiÈmeros 3-piridila e seu uso como analgésicos" | |
| NO20006604L (no) | Fremgangsmåter og transdermale sammensetninger for lindring av smerte | |
| BR0317680A (pt) | Composto, composição farmacêutica, uso de um composto, ou de um sal farmaceuticamente aceitável do mesmo, método de tratamento de um ser humano, e, processo para a preparação de um composto | |
| Horita et al. | The interaction between reversible and irreversible monoamine oxidase inhibitors | |
| EP0824917A3 (en) | Use of a serotonin 5-HTlf agonist in the manufacture of a medicament for treating or ameliorating the symptoms of common cold or allergic rhinitis | |
| BR0011578A (pt) | Utilização do s-enantiÈmero de citalopram para tratamento de distúrbio de ansiedade geral ou ataques de pânico | |
| NZ507303A (en) | Quinolin-4-yl derivatives II and their use in treating neurodegenerative disease | |
| BR9809519A (pt) | Sal, processo para fabricação e uso do mesmo, formulação farmacêutica, e, processo para prevenção ou tratamento de distúrbios cns e perturbações médicas relacionadas | |
| NO892152L (no) | Kondenserte diazepinoner, fremstilling derav og legemidler som inneholder dem. | |
| WO1998022458B1 (en) | Multivalent salts of pyridostigmine and related compounds | |
| KR930002322A (ko) | 피라졸 유도체 | |
| EP1152760A4 (en) | USE OF 4-AMINO PYRIDINE FOR THE TREATMENT OF PERIPHERAL NEUROPATHIES | |
| NO985063L (no) | Pyridyl- og pyrimidyl-piperaziner i behandling av substansmisbruks forstyrr | |
| NO975790D0 (no) | Anvendelse av allylaminderivater slik som terbinafin, i fremstillingen av et medikament for behandling av helikobacterpylori-infeksjonsassosierte sykdommer | |
| Burkhart et al. | Decreased efficacy of topical anesthetic creams in presence of benzoyl peroxide | |
| SE8804640D0 (sv) | Medicament comprising cyclolinopeptide a | |
| Uchida | Clinical efficacy of topical lomefloxacin(NY-198) in bacterial infections of the external eye. | |
| Lewis et al. | Use of convalescent serum in the prevention of chickenpox | |
| RU94044455A (ru) | Средство для усиления функции макрофага и лечения человека с ослабленным иммунитетом | |
| Burningham et al. | A clinical update on fungal disease of human skin | |
| Kaviani et al. | Trial comparing metronidazole and furazolidone (omeprazole, tetracycline, bismuth plus metronidazole vs furazolidone) for eradication of Helicobacter pylori in Iranian peptic ulcer disease patients | |
| Emad et al. | Comparison of topical and oral Ketoconazole in the treatment of intractable Seborrheic dermatitis | |
| AH et al. | < The> comparison between the therapeutic effects of the ultrasound and low-level laser treatment on the healing process of the carpal tunnel syndrome |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |